Grant RadarWorldwide funding

Browse grants Log in Get started

Health Opening SoonRFA-AI-28-018

Improved Drug Susceptibility Testing (DST) for Mycobacteria

National Institutes of Health opportunity RFA-AI-28-018

Eligible Applicants

Organization Types

UniversitiesNGOsSMEsGovernment Agencies

Eligible Countries / Regions

United States

Keywords

National Institutes of HealthRFA-AI-28-018Grants.gov

Related Grants

Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)

Amount not stated

Health Workforce Research Center (HWRC)

Amount not stated

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Amount not stated

23 Dec 2027(412d)

NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Amount not stated

04 Mar 2027(118d)

Funding Amount

Amount not stated

USD

The funder has not published an amount yet — check the call documents.

Programme Details

Programme Code

RFA-AI-28-018